Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

NTP Research Report on Absence of Formaldehyde-Induced Neoplasia in Trp53 Haploinsufficient Mice Exposed by Inhalation: Research Report 3 [Internet].

Morgan DL, Dixon D, King DH, Travlos GS, Herbert RA, French JE, Tokar EJ, Waalkes MP, Jokinen MP.

Durham (NC): National Toxicology Program; 2017 Aug.

PMID:
30016014
Free Books & Documents
2.

Editorial midwifery special issue on education: A call to all the world's midwife educators!

Hundley V, Cadée F, Jokinen M.

Midwifery. 2018 Jun 22. pii: S0266-6138(18)30184-0. doi: 10.1016/j.midw.2018.06.013. [Epub ahead of print] No abstract available.

PMID:
30001842
3.

Establishing a Europe-wide foundation for high quality midwifery education: The role of the European Midwives Association (EMA).

Vermeulen J, Luyben A, Jokinen M, Matintupa E, O'Connell R, Bick D.

Midwifery. 2018 Jun 19. pii: S0266-6138(18)30180-3. doi: 10.1016/j.midw.2018.06.009. [Epub ahead of print]

PMID:
29970310
4.

Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.

Jokinen MP, Morgan DL, Price HC, Herbert RA, Saddler T, Dixon D.

Toxicol Pathol. 2017 Aug;45(6):774-785. doi: 10.1177/0192623317730558.

PMID:
29046139
5.

A Dialogue on the Multiple Facets of Sustainability.

De Clerck GA, Hermann-Shores P, Jokinen M, Lutalo-Kiingi S, Moores DF, Pabsch A, Paul PV, Young A.

Am Ann Deaf. 2017;162(1):39-46. doi: 10.1353/aad.2017.0014.

PMID:
28502915
6.

Ninety-day toxicity and single-dose toxicokinetics study of alpha-glycosyl isoquercitrin in Sprague-Dawley rats.

Nyska A, Hayashi SM, Koyanagi M, Davis JP, Jokinen MP, Ramot Y, Maronpot RR.

Food Chem Toxicol. 2016 Nov;97:354-366. doi: 10.1016/j.fct.2016.09.030. Epub 2016 Sep 28.

7.

Beyond maternal death: improving the quality of maternal care through national studies of ‘near-miss’ maternal morbidity.

Knight M, Acosta C, Brocklehurst P, Cheshire A, Fitzpatrick K, Hinton L, Jokinen M, Kemp B, Kurinczuk JJ, Lewis G, Lindquist A, Locock L, Nair M, Patel N, Quigley M, Ridge D, Rivero-Arias O, Sellers S, Shah A; on behalf of the UKNeS coapplicant group.

Southampton (UK): NIHR Journals Library; 2016 Jun.

8.

Chemical Reactivity and Respiratory Toxicity of the α-Diketone Flavoring Agents: 2,3-Butanedione, 2,3-Pentanedione, and 2,3-Hexanedione.

Morgan DL, Jokinen MP, Johnson CL, Price HC, Gwinn WM, Bousquet RW, Flake GP.

Toxicol Pathol. 2016 Jul;44(5):763-83. doi: 10.1177/0192623316638962. Epub 2016 Mar 29.

9.

Engaging in research.

Rowe R, Jokinen M.

Midwives. 2015 Winter;18:47. No abstract available.

PMID:
26867238
10.

Facilitate a home birth.

Jokinen M, Johnson G.

Midwives. 2015 Spring;18:32-3. No abstract available.

PMID:
25958449
11.

Gastrointestinal immunity against tryptophan hydroxylase-1, aromatic L-amino-acid decarboxylase, AIE-75, villin and Paneth cells in APECED.

Kluger N, Jokinen M, Lintulahti A, Krohn K, Ranki A.

Clin Immunol. 2015 Jun;158(2):212-20. doi: 10.1016/j.clim.2015.03.012. Epub 2015 Mar 21.

PMID:
25805658
12.

Comparative time course profiles of phthalate stereoisomers in mice.

Wood CE, Jokinen MP, Johnson CL, Olson GR, Hester S, George M, Chorley BN, Carswell G, Carter JH, Wood CR, Bhat VS, Corton JC, DeAngelo AB.

Toxicol Sci. 2014 May;139(1):21-34. doi: 10.1093/toxsci/kfu025. Epub 2014 Feb 4.

PMID:
24496636
13.

Environmental pathobiology and global opportunities.

Schmidt SP, Jokinen MP, Law JM, Pandiri AR, Weddle DL, Wolf JC, Sills RC.

Vet Pathol. 2013 Sep;50(5):733-4. doi: 10.1177/0300985813485098. No abstract available.

PMID:
24014610
14.

Gastrointestinal manifestations in APECED syndrome.

Kluger N, Jokinen M, Krohn K, Ranki A.

J Clin Gastroenterol. 2013 Feb;47(2):112-20. doi: 10.1097/MCG.0b013e31827356e1. Review.

PMID:
23314667
15.

What is the burden of living with autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED) in 2012? A health-related quality-of-life assessment in Finnish patients.

Kluger N, Jokinen M, Krohn K, Ranki A.

Clin Endocrinol (Oxf). 2013 Jul;79(1):134-41. doi: 10.1111/cen.12087. Epub 2013 Apr 13.

PMID:
23113742
16.

Bronchial and bronchiolar fibrosis in rats exposed to 2,3-pentanedione vapors: implications for bronchiolitis obliterans in humans.

Morgan DL, Jokinen MP, Price HC, Gwinn WM, Palmer SM, Flake GP.

Toxicol Pathol. 2012 Apr;40(3):448-65. doi: 10.1177/0192623311431946. Epub 2012 Jan 3.

PMID:
22215510
17.

Guidelines for prevention and control of group A streptococcal infection in acute healthcare and maternity settings in the UK.

Steer JA, Lamagni T, Healy B, Morgan M, Dryden M, Rao B, Sriskandan S, George R, Efstratiou A, Baker F, Baker A, Marsden D, Murphy E, Fry C, Irvine N, Hughes R, Wade P, Cordery R, Cummins A, Oliver I, Jokinen M, McMenamin J, Kearney J.

J Infect. 2012 Jan;64(1):1-18. doi: 10.1016/j.jinf.2011.11.001. Epub 2011 Nov 17.

PMID:
22120112
18.

Effects of capsid-modified oncolytic adenoviruses and their combinations with gemcitabine or silica gel on pancreatic cancer.

Kangasniemi L, Parviainen S, Pisto T, Koskinen M, Jokinen M, Kiviluoto T, Cerullo V, Jalonen H, Koski A, Kangasniemi A, Kanerva A, Pesonen S, Hemminki A.

Int J Cancer. 2012 Jul 1;131(1):253-63. doi: 10.1002/ijc.26370. Epub 2011 Sep 14.

19.

Morphologic aspects of rodent cardiotoxicity in a retrospective evaluation of National Toxicology Program studies.

Jokinen MP, Lieuallen WG, Boyle MC, Johnson CL, Malarkey DE, Nyska A.

Toxicol Pathol. 2011 Aug;39(5):850-60. doi: 10.1177/0192623311413788. Epub 2011 Jul 11.

PMID:
21747121
20.

Use of decision analysis interviews to support the sustainable use of the forests in Finnish Upper Lapland.

Mustajoki J, Saarikoski H, Marttunen M, Ahtikoski A, Hallikainen V, Helle T, Hyppönen M, Jokinen M, Naskali A, Tuulentie S, Varmola M, Vatanen E, Ylisirniö AL.

J Environ Manage. 2011 Jun;92(6):1550-63. doi: 10.1016/j.jenvman.2011.01.007. Epub 2011 Feb 1.

PMID:
21288630
21.

Thyroid follicular lesions induced by oral treatment for 2 years with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds in female Harlan Sprague-Dawley rats.

Yoshizawa K, Walker NJ, Nyska A, Kissling GE, Jokinen MP, Brix AE, Sells DM, Wyde ME.

Toxicol Pathol. 2010 Dec;38(7):1037-50. doi: 10.1177/0192623310382560. Epub 2010 Oct 5.

PMID:
20924081
22.

Look out for the limitations.

Stockdale J, Jokinen M, Macdonald S.

Midwives. 2010 Sep:15. No abstract available.

PMID:
24888166
23.

Risky business.

Bartholomew A, Jokinen M.

Midwives. 2009 Dec-2010 Jan;12(6):40-1. No abstract available.

PMID:
24908720
24.

Reproductive lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin and dioxin-like compounds.

Yoshizawa K, Brix AE, Sells DM, Jokinen MP, Wyde M, Orzech DP, Kissling GE, Walker NJ, Nyska A.

Toxicol Pathol. 2009 Dec;37(7):921-37. doi: 10.1177/0192623309351721.

PMID:
19843953
25.

Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II).

Milne F, Redman C, Walker J, Baker P, Black R, Blincowe J, Cooper C, Fletcher G, Jokinen M, Moran PA, Nelson-Piercy C, Robson S, Shennan A, Tuffnell A, Waugh J; PRECOG II Group.

BMJ. 2009 Sep 9;339:b3129. doi: 10.1136/bmj.b3129. No abstract available.

PMID:
19740933
26.

Extended release of adenovirus from silica implants in vitro and in vivo.

Kangasniemi L, Koskinen M, Jokinen M, Toriseva M, Ala-Aho R, Kähäri VM, Jalonen H, Ylä-Herttuala S, Moilanen H, Stenman UH, Diaconu I, Kanerva A, Pesonen S, Hakkarainen T, Hemminki A.

Gene Ther. 2009 Jan;16(1):103-10. doi: 10.1038/gt.2008.142. Epub 2008 Aug 28.

PMID:
18754041
27.

Making normal labour and birth a reality--developing a multi disciplinary consensus.

Werkmeister G, Jokinen M, Mahmood T, Newburn M.

Midwifery. 2008 Sep;24(3):256-9. doi: 10.1016/j.midw.2008.06.001. Epub 2008 Jul 30. No abstract available.

PMID:
18672321
28.

Pulmonary lesions in female Harlan Sprague-Dawley rats following two-year oral treatment with dioxin-like compounds.

Walker NJ, Yoshizawa K, Miller RA, Brix AE, Sells DM, Jokinen MP, Wyde ME, Easterling M, Nyska A.

Toxicol Pathol. 2007 Dec;35(7):880-9.

29.

Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, Diaz M.

J Immunol. 2007 Jun 1;178(11):7422-31.

30.

Sol-gel-derived TiO(2)-SiO (2) implant coatings for direct tissue attachment. Part I: design, preparation and characterization.

Aäritalo V, Areva S, Jokinen M, Lindén M, Peltola T.

J Mater Sci Mater Med. 2007 Sep;18(9):1863-73. Epub 2007 May 17.

PMID:
17508132
31.

Sol-Gel-derived TiO2-SiO2 implant coatings for direct tissue attachment. Part II: Evaluation of cell response.

Areva S, Aäritalo V, Tuusa S, Jokinen M, Lindén M, Peltola T.

J Mater Sci Mater Med. 2007 Aug;18(8):1633-42.

PMID:
17483880
32.

Comparison between sol-gel-derived anatase- and rutile-structured TiO2 coatings in soft-tissue environment.

Rossi S, Moritz N, Tirri T, Peltola T, Areva S, Jokinen M, Happonen RP, Närhi T.

J Biomed Mater Res A. 2007 Sep 15;82(4):965-74.

PMID:
17335031
33.

Respiratory tract lesions in noninhalation studies.

Sells DM, Brix AE, Nyska A, Jokinen MP, Orzech DP, Walker NJ.

Toxicol Pathol. 2007 Jan;35(1):170-7. Review.

34.

Mechanistic studies on release of large and small molecules from biodegradable SiO2.

Viitala R, Jokinen M, Rosenholm JB.

Int J Pharm. 2007 May 24;336(2):382-90. Epub 2006 Dec 10.

PMID:
17292572
35.

Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease.

Jokinen MJ, Neuvonen PJ, Lindgren L, Höckerstedt K, Sjövall J, Breuer O, Askemark Y, Ahonen J, Olkkola KT.

Anesthesiology. 2007 Jan;106(1):43-55.

PMID:
17197844
36.

Artery regional properties and atherosclerosis susceptibility.

Wagner WD, Guo F, Jokinen MP.

Life Sci. 2007 Jan 2;80(4):299-306. Epub 2006 Sep 23.

PMID:
17084416
37.

Effect of short-term water storage on the elastic properties of some dental restorative materials--A resonant ultrasound spectroscopy study.

Pastila P, Lassila LV, Jokinen M, Vuorinen J, Vallittu PK, Mäntylä T.

Dent Mater. 2007 Jul;23(7):878-84. Epub 2006 Sep 1.

PMID:
16949660
38.

The utility of the guppy (Poecilia reticulata) and medaka (Oryzias latipes) in evaluation of chemicals for carcinogenicity.

Kissling GE, Bernheim NJ, Hawkins WE, Wolfe MJ, Jokinen MP, Smith CS, Herbert RA, Boorman GA.

Toxicol Sci. 2006 Jul;92(1):143-56. Epub 2006 Mar 31.

PMID:
16581948
39.

Biomimetic mineralization of partially bioresorbable glass fiber reinforced composite.

Väkiparta M, Forsback AP, Lassila LV, Jokinen M, Yli-Urpo AU, Vallittu PK.

J Mater Sci Mater Med. 2005 Sep;16(9):873-9.

PMID:
16167117
40.

Effect of cross-sectional design on the modulus of elasticity and toughness of fiber-reinforced composite materials.

Dyer SR, Lassila LV, Jokinen M, Vallittu PK.

J Prosthet Dent. 2005 Sep;94(3):219-26.

PMID:
16126074
41.

Characterization of spontaneous and chemically induced cardiac lesions in rodent model systems: the national toxicology program experience.

Jokinen MP, Lieuallen WG, Johnson CL, Dunnick J, Nyska A.

Cardiovasc Toxicol. 2005;5(2):227-44.

PMID:
16046796
42.

Incidences of selected lesions in control female Harlan Sprague-Dawley rats from two-year studies performed by the National Toxicology Program.

Brix AE, Nyska A, Haseman JK, Sells DM, Jokinen MP, Walker NJ.

Toxicol Pathol. 2005;33(4):477-83.

PMID:
16036865
43.

The pharmacokinetics of ropivacaine in hepatic and renal insufficiency.

Jokinen MJ.

Best Pract Res Clin Anaesthesiol. 2005 Jun;19(2):269-74. Review.

PMID:
15966497
44.

Olfactory epithelial metaplasia and hyperplasia in female Harlan Sprague-Dawley rats following chronic treatment with polychlorinated biphenyls.

Nyska A, Yoshizawa K, Jokinen MP, Brix AE, Sells DM, Wyde ME, Orzech DP, Kissling GE, Walker NJ.

Toxicol Pathol. 2005;33(3):371-7.

PMID:
15805076
45.

Classification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds.

Hailey JR, Walker NJ, Sells DM, Brix AE, Jokinen MP, Nyska A.

Toxicol Pathol. 2005;33(1):165-74.

PMID:
15805068
46.

The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community.

Milne F, Redman C, Walker J, Baker P, Bradley J, Cooper C, de Swiet M, Fletcher G, Jokinen M, Murphy D, Nelson-Piercy C, Osgood V, Robson S, Shennan A, Tuffnell A, Twaddle S, Waugh J.

BMJ. 2005 Mar 12;330(7491):576-80. No abstract available.

47.

Dose-additive carcinogenicity of a defined mixture of "dioxin-like compounds".

Walker NJ, Crockett PW, Nyska A, Brix AE, Jokinen MP, Sells DM, Hailey JR, Easterling M, Haseman JK, Yin M, Wyde ME, Bucher JR, Portier CJ.

Environ Health Perspect. 2005 Jan;113(1):43-8.

48.

Gingival carcinogenicity in female Harlan Sprague-Dawley rats following two-year oral treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin and dioxin-like compounds.

Yoshizawa K, Walker NJ, Jokinen MP, Brix AE, Sells DM, Marsh T, Wyde ME, Orzech D, Haseman JK, Nyska A.

Toxicol Sci. 2005 Jan;83(1):64-77. Epub 2004 Oct 27. Erratum in: Toxicol Sci. 2005 Feb;83(2):405-6.

PMID:
15509667
49.

Effect of fiber position and orientation on fracture load of fiber-reinforced composite.

Dyer SR, Lassila LV, Jokinen M, Vallittu PK.

Dent Mater. 2004 Dec;20(10):947-55.

PMID:
15501323
50.

Characterisation of bioactive glass coatings on titanium substrates produced using a CO2 laser.

Moritz N, Vedel E, Ylänen H, Jokinen M, Hupa M, Yli-Urpo A.

J Mater Sci Mater Med. 2004 Jul;15(7):787-94.

PMID:
15387414

Supplemental Content

Loading ...
Support Center